ABL Bio

298380.KQ

138.87 USD

-7.63

-5.21%

Overview

Last close

138.87 usd

Market cap

7.66B usd

52 week high

146.50 usd

52 week low

18.25 usd

Target price

86.02 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

125.2894

Price/Book Value

59.1272

Enterprise Value

7.39B usd

EV/Revenue

120.9143

EV/EBITDA

-32.1061

Key financials

Revenue TTM

61.10M usd

Gross Profit TTM

61.06M usd

EBITDA TTM

-18.48M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

167.77M usd

Net debt

N/A usd

About

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is based in Seoul, South Korea.